13,14-DIHYDRO-15-KETO PROSTAGLANDIN E1 Chemical Properties

Boiling point:

537.2±35.0 °C(Predicted)

Density 

1.072±0.06 g/cm3(Predicted)

storage temp. 

-20°C Freezer, Under inert atmosphere

solubility 

DMSO (Slightly), Methanol (Slightly), THF (Slightly)

form 

Oil

pka

4.77±0.10(Predicted)

color 

Dark Yellow

13,14-DIHYDRO-15-KETO PROSTAGLANDIN E1 Usage And Synthesis

Description

13,14-dihydro-15-keto Prostaglandin E₁ (PGE₁) is a metabolite of PGE₁ with much reduced biological activity. Steady state plasma concentrations are about 10 pg/ml. 13,14-dihydro-15-keto PGE₁ is a weak inhibitor of ADP-induced platelet aggregation in human PRP and washed platelets with IC₅₀ values of 54 and 200 μM, respectively, compared to PGE₁ which has an IC₅₀ of 40 nM.

Uses

15-Keto Prostaglandin E0 is a metabolite of Prostaglandin E1 (P838600) and has been shown to induce arterial thromboresistance in experimental animals and in man, but with several magnitudes higher concentrations than Prostaglandin E1. 15-Keto Prostaglandin E0 is also used as the active ingredient in compositions used for the treatment of external secretion disorders.

Definition

ChEBI: 13,14-dihydro-15-oxoprostaglandin E1 is a prostaglandin E obtained by formal oxidation of the 15-hydroxy group and hydrogenation of the 13,14-double bond of prostaglandin E1. It has a role as a human xenobiotic metabolite. It is functionally related to a prostaglandin E1. It is a conjugate acid of a 13,14-dihydro-15-oxoprostaglandin E1(1-).

13,14-DIHYDRO-15-KETO PROSTAGLANDIN E1(5094-14-4)Related Product Information

• 8-[(3S,4S)-4α-[(Z)-2-Pentenyl]-5-oxo-1-cyclopentene-3α-yl]octanoic acid
• 15-Hydroxy Lubiprostone
• 13,14-DIHYDRO-15(R)-PROSTAGLANDIN E1
• 11BETA-PROSTAGLANDIN E1
• 13,14-DIHYDROPROSTAGLANDIN E1
• 11-DEOXY PROSTAGLANDIN E1
• 15-KETO PROSTAGLANDIN E1
• 13,14-DIHYDRO-15-KETO PROSTAGLANDIN E1-D4
• 13,14-DIHYDRO-15-KETO PROSTAGLANDIN E1